Akèy › Distrofi Miskilè Duchenne › Arkansas
Etid klinik pou Distrofi Miskilè Duchenne nan Arkansas
7 etid pou Distrofi Miskilè Duchenne ap chèche patisipan nan sit nan Arkansas.
Vil nan Arkansas
Tèks ofisyèl etid la (Anglè)
A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)
- Arkansas Children's Hospital, Little Rock
Ap rekriteFaz 3
Laj 7 a 11 · Gason · Mizajou Sep 28, 2026 · NCT07160634A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) - Non-Ambulatory Cohort
- Arkansas Children's Hospital, Little Rock
Ap rekriteFaz 1
Laj 2 ak plis · Gason · Mizajou Sep 11, 2026 · NCT04626674A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)
- Arkansas Children's Hospital, Little Rock
Ap rekriteFaz 1/2
Laj 0 a 17 · Gason · Mizajou Jul 8, 2026 · NCT06138639A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy
- Arkansas Children's Research Institute, Little Rock
Ap rekriteEtid obsèvasyon
Laj 6 ak plis · Tout sèks · Mizajou Jul 2, 2026 · NCT07127978PBGENE-DMD Phase 1/2a Safety and Preliminary Efficacy Study in Duchenne Muscular Dystrophy (FUNCTION-DMD)
- Arkansas Children's Hospital, Little Rock
Ap rekriteFaz 1/2
Laj 2 a 7 · Gason · Mizajou Jun 23, 2026 · NCT07429240Duchenne Electronic Health Record Study
- Arkansas Children's Hospital, Little Rock
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou May 27, 2026 · NCT07609394Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
- Arkansas Children's Hospital, Little Rock
Ap rekriteFaz 1/2
Laj 4 a 18 · Gason · Mizajou Dec 15, 2025 · NCT04906460Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.